Rereading the Annamycin trial press release again, the reported number of lines are actually the actual number of lines of treatment (whereas the Bisantrene lines figures are prior lines of treatment). So the median number of lines of PRIOR treatment in the Annamycin trial was one (versus four for Bisantrene).
- Forums
- ASX - By Stock
- Cardioprotection thread
Rereading the Annamycin trial press release again, the reported...
Featured News
Add RAC (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.58 |
Change
0.055(3.62%) |
Mkt cap ! $268.4M |
Open | High | Low | Value | Volume |
$1.56 | $1.61 | $1.56 | $106.0K | 67.13K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 649 | $1.58 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.59 | 3000 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 649 | 1.575 |
1 | 325 | 1.540 |
1 | 1138 | 1.535 |
1 | 10000 | 1.525 |
1 | 2239 | 1.520 |
Price($) | Vol. | No. |
---|---|---|
1.585 | 3000 | 1 |
1.620 | 2192 | 2 |
1.630 | 6183 | 1 |
1.640 | 4440 | 2 |
1.660 | 20000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
RAC (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online